Oct 8 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ (REGN.O), opens new tab immunotherapy, Libtayo, as an add-on treatment for skin cancer patients ...
Communities often celebrate data center openings. But for all the benefits state and local officials tout for the massive facilities, they also bring their share of problems — including gobbling up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback